We further demonstrate that CRISPR/Cas9-engineered human HCC cell lines with inactivated plectin display limited migration, invasion, and anchorage-independent proliferation which correlates with their reduced metastatic outgrowth in the lung. Here, PLEC is linked to hepatocellular carcinoma.